Ex-FDA chief’s startup nabs $140M for cancer diagnostics


Harbinger Health, a startup led by the former FDA head under President Donald Trump, is putting $140 million in new funds to work on a cancer diagnostic.

Previous UB School of Dental Medicine prepares for $2.6M expansion
Next Cingulate weighs reverse stock split to avoid delisting